Abstract:Background: Peptide nucleic acid (PNA) plays an important role in antimicrobial activity, but its cellular permeability is poor. To overcome this limitation, we constructed biomimetic nanoparticles by using extracellular vesicle (EV)-coated mesoporous silicon nanoparticles (MSNs) to deliver PNA to Staphylococcus aureus (S. aureus) and improve its antisense therapeutic effect. Method: MSN was prepared by the sol-gel method, and EV was extracted by affinity resin chromatography. EV was coated on MSN by simple sonication (50 W, 3 min) to prepare biomimetic nanoparticles with PNA-loaded MSN as the core and EV isolated from S. aureus as the shell. Results: The MSN prepared by the sol-gel method had a uniform particle size (100 nm) and well-defined pore size for loading PNA with good encapsulation efficiency (62.92%) and drug loading (7.74%). The concentration of EV extracted by affinity resin chromatography was about 1.74 mg/mL. EV could be well coated on MSN through simple ultrasonic treatment (50 W, 3 min), and the stability and blood compatibility of MSN@ EV were good. Internalization experiments showed that EV could selectively enhance the uptake of biomimetic nanoparticles by S. aureus. Preliminary in vitro antibacterial tests revealed that PNA@MSN@EV exhibited enhanced antibacterial activity against S. aureus and had stronger bactericidal activity than free PNA and PNA@MSN at equivalent PNA concentrations (8 μM). Conclusion: Biomimetic nanoparticles based on EV-coated MSN offer a new strategy to improve the efficacy of PNA for the treatment of bacterial infections, and the technology holds promise for extension to the delivery of antibiotics that are traditionally minimally effective or prone to resistance.

Recent applicable delivery approaches of peptide nucleic acids to the target cells

Cellular delivery of modified peptide nucleic acids: a review

Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery

Walking through the wonder years of artificial DNA: peptide nucleic acid

Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics

Potential applications of peptide nucleic acid in biomedical domain

Cell-Penetrating Peptides as Vehicles for Delivery of Therapeutic Nucleic Acids. Mechanisms and Application in Medicine

Recognition of Target Site in Various Forms of DNA and RNA by Peptide Nucleic Acid (PNA): from Fundamentals to Practical Applications

The challenge of peptide nucleic acid synthesis

Peptide nucleic acid conjugates and their antimicrobial applications—a mini-review

Application of Peptide Nucleic Acid in Molecular Biotechnology

Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides

Recent Advances of Nanocarriers for Effective Delivery of Therapeutic Peptides

Recent Advances In Peptide Nucleic Acids As Antibacterial Agents

Recent advances in peptide nucleic acid for cancer bionanotechnology

Delivery of nucleic acids using nanomaterials

Versatility of peptide nucleic acids (PNAs): role in chemical biology, drug discovery, and origins of life

Targeted Delivery of Peptide Nucleic Acid by Biomimetic Nanoparticles Based on Extracellular Vesicle-coated Mesoporous Silica Nanoparticles

Receptor-Specific Delivery of Peptide Nucleic Acids Conjugated to Three Sequentially Linked N-Acetyl Galactosamine Moieties into Hepatocytes.

Aptamer-Based Targeted Delivery of Functional Nucleic Acids.

Delivery of Cell-Penetrating Peptide-Peptide Nucleic Acid Conjugates by Assembly on an Oligonucleotide Scaffold.